Brief: Seres Therapeutics Files Prospectus Related To Resale Of Up To 14.3 Million Shares Of Common Stock
Oct 1 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS FILES PROSPECTUS RELATED TO RESALE,FROM
TIME
TO TIME, OF UP TO 14.3 MILLION SHARES OF COMMON STOCK BY
SELLING STOCKHOLDER- SEC FILING
Source text for Eikon: ID:n0001193125-24-230253
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47